AI Can Harness SaaS in Healthcare Through a Variety of Different and Advanced Tools

 

For a special segment of HealthTrio, the topic turns to the innovative use of SaaS in healthcare, which is currently a trending subject at the forefront of modern medical technology. The episode briefly looked into how SaaS platforms are revolutionizing healthcare management and patient outcomes.

This episode featured Geoffrey M. Roche, the Executive Advisor at the Executive Advisor of National Health Care Practice at Core Education PBC and a seasoned healthcare professional with more than a decade of experience as a hospital administrator. Roche shared his thoughts into the role of SaaS in the health field and emphasized its potential to improve patient outcomes and advance health equity. He highlighted capabilities in SaaS healthcare platforms and how it has greatly changed health. Roche also stressed the importance of technology, like AI, in the shift towards value-based care, noting how SaaS assists healthcare organizations to increase the likelihood of positive changes and efforts. He further touched on the benefits of using SaaS and its impact in the healthcare sector from his perspective as an experienced practitioner in the field.

Article written by Alexandra Simon.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…